semaj83/ctmatch_classification huggingface dataset:
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Squamous Cell Carcinoma of the Head and Neck Human Papilloma Virus Histologically or cytologically confirmed squamous cell carcinoma of the oropharynx or unknown primary that is HPV 16 positive as determined by ISH and p16 positive as determined by IHC Stage 3 or 4 disease without evidence of distant metastases At least one evaluable or uni or bi-dimensionally measurable lesion by 1.1 years of age or older No previous surgery, radiation therapy or chemotherapy for SSCHN is allowed at time of study entry ECOG Performance Status of 0 or 1 No active alcohol addiction Adequate bone marrow, hepatic and renal function as defined in the protocol Women of child-bearing potential must have a negative pregnancy test within 7 days of starting treatment  Pregnant or breast feeding women or women and men of childbearing potential not willing to use adequate contraception while on treatment and for at least 3 months after Previous or current malignancies at other sites Symptomatic peripheral neuropathy of grade 2 or greater Symptomatic altered hearing greater than grade 2 Other serious illnesses or medical conditions Patients that have experienced an involuntary weight loss of more than 25% of their body weight in the 2 months preceding study entry Concurrent treatment with any other anticancer therapy Participation in an investigational trial within 30 days of study entry
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cystic Fibrosis Male or female participants with confirmed diagnosis of CF Must have the F508del-CFTR mutation on at least 1 allele FEV1 greater than equal (>=) 40% of predicted normal for age, gender, and height (Knudson standards)(Cohort 1, 2, and 3); FEV1 40-90% of predicted normal for age, gender, and height (Hankinson standards (Cohort 4) Participant of child-bearing potential and who are sexually active must meet the contraception requirements  History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk in administering study drug to the participant (e.g., cirrhosis with portal hypertension) An acute illness including acute upper or lower respiratory infection, pulmonary exacerbation or changes in therapy (including antibiotics) for pulmonary disease within 14 days (Cohort 1, 2, and 3) or 28 days (Cohort 4) before receiving the first dose of study drug History of solid organ or hematological transplantation History of alcohol abuse or drug addiction in the past year, including cannabis, cocaine, and opiates Ongoing participation in another therapeutic clinical study, or prior participation in an investigational drug study without appropriate washout Pregnant or nursing females; females of childbearing potential who are unwilling or unable to use an acceptable method of non-hormonal contraception Participants enrolled in Cohort 1 or Cohort 2 will not be eligible for Cohort 3 Ongoing or prior participation in an investigational drug study within 30 days of the Screening Visit Heterozygous participants who participated in Cohort 2 and meet the for Cohort 4 may participate in Cohort 4 Evidence of lens opacity or cataract as determined by the ophthalmologic examination (Cohort 4 only)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  1- Women 2- HIV Infection 3- Followed in West Indies and French Guiana for His Infection 4- Acceptance of the Use of Nadis® Medical Files Women aged 18 years old or beyond Infected with HIV1 or HIV2 Follow up for HIV infection in one of the center participating in the study and acceptance of the use of Nadis® medical files in one of the center participating in the study and acceptance of the use of Nadis® medical files within the context of follow up that should be realized according to the recommandation of undertaking: systematic Pap smear for asymptomatic patient s (expert's report, Pr.P.Yéni) or Pap smear for classical searching of any pathology of the uterine-cervix Acceptance of involvement into the study and collection of non opposition to the realization of HPV search from the sample realized for the Pap smear  Women under age History of total hysterectomy Patient not followed for HIV infection in one of the center involved in the study Patient that did not accept the use of Nadis® medical files Impossibility to realize a Pap smear Refusal of study's participation
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  DNA Probes E6 Protein Uterine Cervical Neoplasms HPV have not been previously diagnosed with cervical cancer 2. have a cervix 3. are not pregnant 4. are physically able to undergo routine cervical cancer screening 5) are able to provide informed consent We will not women if they have had previous cervical cancer screening because we assume that even if a few women have been screened for cervical cancer, the quality of cytology screening was very poor  are not married AND report never having had sexual intercourse 2) have had a total hysterectomy 3) have a history of cervical cancer 4) are physically or mentally unable to undergo routine cervical cancer screening or unable to provide informed consent. 5) are pregnant or have been pregnant in the last month -Women who are currently menstruating at the time of enrollment will be deferred from participating, and will become eligible to participate 7-14 days after menstruation has ended. The menstruating women will be advised to return for the screening 7 to 14 days after their menstrual period has concluded
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Lupus Erythematosus Diagnosed with cutaneous lupus erythematosus and/or systemic lupus erythematosus by clinical, laboratory, and histopathological findings Ability to speak and read English or Spanish at a 6th grade reading level (a translator will be available with additional consent forms in Spanish) Ability to give written informed consent  Less than 18 years of age, since the characteristics of the disease in these subjects could be very different Due to a medication, in which its discontinuation results in the resolution of cutaneous lupus, since the characteristics of the disease in these subjects could be very different Medical conditions who do not warrant a skin biopsy Unable to give written, informed consent or undergo a skin biopsy and/or venipuncture for any other reason
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Intraepithelial Neoplasia Women aged ≥18 years diagnosed with histologically verified CIN 3 and women aged ≥ 30 years diagnosed with CIN 2 2. Satisfactory colposcopy 3. Signed informed consent 4. Negative pregnancy test 5. Appropriate contraception method for fertile women during active study period 6. Adequate compliance  Adenocarcinoma in situ 2. History of previous conization 3. Malignant disease at the time of 4. Colposcopy suspicious for invasive disease 5. Pregnancy and lactation period 6. Known allergy or intolerance to IMQ 7. Contraindications to conization or IMQ 8. Symptoms of a clinically relevant disease 9. Known HIV infection 10. Evidence of a clinically significant immunodeficiency 11. Current, reported participation in another experimental, interventional protocol
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Diabetes Mellitus Adult Healthy or having controlled type 2 diabetes mellitus  Morbid obesity (BMI > 40) Presence of gastroenterological disorders Alimentary tract surgery A history of gastroenteritis in the prior six months Any disease that may affect glucose metabolism Alcohol intake Smoking Taking any medications (except metformin) Poorly uncontrolled diabetes (HbA1c > 8%) The presence of chronic diseases or the presence of acute illness
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 11.0-999.0,  Tooth; Lesion, White Spot Lesions Written informed consent Healthy volunteers (≥11 years) scheduled for bracket removal ≥ 1 WSL with a modified score 1 or 2 (Gorelick et al. 1982) on UFT at debonding  Known hypersensitivity or allergy to study products and standard toothpaste ingredients and/or dental material used in the present study Known hypersensitivity or allergy to placebo gel ingredients Alterations in the teeth's enamel, e.g. hypoplasia, fluorosis Any illness/condition potentially affecting the study outcome at investigator's discretion Known pregnancy or breast feeding during the course of the study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Very Low Birth Weight Baby Pneumonia A cluster was eligible to participate if it Is located in Kintampo North or South Districts (this is the core study area for KHRC) Is primarily rural (in practice, this excludes Kintampo, which is a small city of approximately 40,000 people) Is operationally feasible (in practice, this excluded a handful very small, isolated clusters that would have presented extraordinary logistical challenges) Is home to women who primarily deliver at one of our four staffed birth facilities (in practice this excluded one village on the edge of the study area, in which women travel to another district for deliveries). A woman will be eligible to participate in the study if she Is in the first or second trimester of pregnancy (gestational age ≤ 24 weeks gestation; this is to ensure that the intervention is actually delivered prior to 27 weeks) Is carrying a live singleton fetus (twins will be excluded) Is the primary cook in her household or compound; and Is a non-smoker
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Alcohol Consumption Unsafe Sex Male and female patients older than 18 who receive medical care in the ED *score positive (> 8 for males; > 6 for females) for harmful alcohol use on the AUDIT screening questionnaire and report past 3-month binge drinking be sexually active (past 6 months) endorse any past-year sex-risk behavior criterion, including having more than one sexual partner having sexual intercourse without a condom consuming alcohol prior to or during sex sing illicit drugs (or using licit drugs to get high) prior to or during sex  Patients under the age of 18; Patients in a mutually monogamous relationship for longer than 1 year will be excluded unless either the patient or his/her partner are HIV+ or has unknown HIV status. Other scoring below 18 on a mini-mental status exam no verifiable address plans to move outside a 45-mile radius within the follow-up period
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 17.0-999.0,  Pre Term Labor Multiple Pregnancy She is >=24weeks 0days but less than 36 completed weeks, with a singleton pregnancy or >=34weeks 0days with a multiple pregnancy and has been admitted to the Labor and Delivery Unit She is in the latent phase of spontaneous labor, or has been admitted for induction of labor She has given her informed consent to participate as a subject She has none of the  Known major fetal malformation or chromosome abnormality Involvement in another clinical trial currently or previously in this pregnancy Medical or obstetric problem that would preclude the use of abdominal electrodes (e.g., skin eruptions, sensitivity to adhesives) Significant medical or obstetric problem that in the investigator's opinion would make the woman incapable of taking part in the study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 30.0-70.0,  Uterine Cervical Neoplasms 994 women from 30 to 70 years of age with incorrect screening (data obtained from Electronic Medical Records) ascribed to the Basic Health Care Area will be included in the study. Incorrect screening will be defined as [9]: 1 No cytology in the last 3 years from women between 30 to 40 years, 2 No cytology in the previous 5 years from women between 40 to 65 years, 3 No previous cytology history for females older than 65 years or women who have not had their last cytology before the age of 60  hysterectomised women, with a current history of pre-malignant lesions (Atypical glandular cells of undetermined significance, Atypical squamous cells of undetermined significance, Low grade Squamous Intraepithelial Lesion, High grade Squamous Intraepithelial Lesion), carcinoma in situ and cervical-uterine cancer, HIV positive or other causes of immunosuppression (since these women follow a specific protocol) those residing outside the study setting for more than 6 months those ascribed to the study Basic Health Care Area but with a physician assigned in an UBA (General Practicioner and Nurse Team) of another zone different from the one considered in the study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Human Papillomavirus Infection • the subject attended a colposcopy visit, and the referral Pap sample had a valid HPV Assay result, and the sample had an HPV Assay positive result, or the sample had an HPV Assay negative result and the subject had a consensus histology result of cervical intraepithelial neoplasia (CIN) grade 2 [CIN2] or more severe (eg, CIN2, CIN grade 3 [CIN3], or cervical cancer; "CIN2+"), or the sample had an HPV Assay negative result and the subject had a consensus histology result of normal or CIN grade 1 (<CIN2) and was randomly selected for inclusion. the referral Pap sample had a valid HPV Assay result, and the sample had an HPV Assay positive result, or the sample had an HPV Assay negative result and the subject had a consensus histology result of CIN2+, or the sample had an HPV Assay negative result and the subject had a consensus histology result of <CIN2 and was randomly selected for inclusion  Samples from evaluable subjects meeting the sample will not be tested with the AHPV-GT Assay if there is insufficient volume for AHPV-GT Assay testing or the sample was deemed unsuitable for testing (eg, stored under unacceptable conditions)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Cervical Cancer Women aged 18-65 with a cytological diagnosis of CIN2+cervical lesions from all over Croatia that are referred to National Reference Center because of HSIL or malignant cytology findings  Women younger than 18 or older than 65 Pregnant women
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Uterine Cervical Dysplasia antecedent biopsy read as cervical intraepithelial neoplasia (CIN) grade 2 or 3 or microinvasive cancer adenocarcinoma in situ persistent CIN 1 antecedent pap read as high grade squamous intraepithelial lesion atypical glandular cells persistent low grade squamous intraepithelial lesion  anatomy unsuitable for safe office loop excision based on operator judgement inability to tolerate procedure under local anesthesia pregnancy age less than 18 years inability to understand spoken or written English refusal of consent prisoner mental incapacity anticoagulant or antiplatelet therapy, or known bleeding diathesis use of analgesics other than over the counter medications(OTC meds or Tylenol) within 7 days of scheduled LEEP
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 21.0-999.0,  Cervical Cancer LSIL Women 21 years of age or greater with recent LSIL who are scheduled for colposcipal assessment Women with previous or current STD or HIV may be included Women with previous LSIL history may be included  pregnant women women with vaginal intraepithelial lesions women on a chemotherapeutic agent women with previous or current cancer except for non-cervical squamous cell carcinoma
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Diabetes Mellitus required that those in the healthy group were healthy and in the diabetes group that their diabetes was controlled (HbA1c ≤8%) on diet with or without metformin  morbid obesity (BMI > 40 kg/m2) pre diabetes pregnancy presence of gastroenterological disorders alimentary tract surgery a history of gastroenteritis in the prior six months any alcohol intake smoking taking any medications (except metformin) poorly controlled diabetes (HbA1c > 8%) and the presence of acute or chronic diseases
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-49.0,  Endometriosis Women 18 years of age or older Women of reproductive age (less than 50 years) undergoing diagnostic laparoscopy for suspected endometriosis Willingness to provide informed consent  Pregnancy General health issues that the physician determines would make laparoscopy unsafe
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 50.0-65.0,  Osteoporosis Caucasian Female Natural or surgical menopause between 1 and 5 years Aged between 50 to 65 years BMI between 19 and 30 kg/m²  Medications: oral steroidal anti-inflammatory, anti-osteoporotic treatment, hormone replacement therapy Low bone mineral density (T-score<-3 Diseases affecting bone metabolism(Paget's disease, Cushing's disease, thyroid disease...) Intolerance or allergy to milk proteins and allergy to soy or soy lecithin Heavy smoking Excessive alcohol drinking Intensive sports practice according to the investigator